Tag: biosimilars

Healthcare Drug Spending: How Generics Cut Costs Without Compromising Care

Generics make up 90% of U.S. prescriptions but only 12% of drug spending, saving billions annually. Learn how they work, why they’re cheaper, and why they’re the most effective tool for controlling healthcare costs.

Learn More

The Purple Book: Understanding FDA-Approved Biosimilars and Interchangeable Products

The FDA's Purple Book is the official guide to approved biosimilars and interchangeable biological products in the U.S. Learn how it works, what interchangeability means, and how it affects your treatment options.

Learn More